Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation: Kemira to publish January-September 2023 results on October 24, 2023

Kemira Oyj, Press Release, October 10, 2023 at 9.00 am (EEST)Invitation: Kemira to publish January-September 2023 results on October 24, 2023   Kemira Oyj will publish its January-September 2023 results on Tuesday, October 24, 2023 around 8.30 am Finnish time (6.30 am UK time).  Webcast for analysts, investors, and media will be held on Tuesday, October 24, 2023, starting at 10.30 am (8.30 am UK time). At the webcast, Kemira’s Interim President and CEO, CFO Petri Castrén will present the results. The webcast will be held in English and can be followed at kemira.com/investors (

Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS)

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, successfully attended the American Foregut Society (AFS) 2023 Annual Meeting held in Dallas, Texas. The meeting included a panel discussion on RefluxStop with 4 leading European KOLs and was moderated by the former president of AFS.The panel reviewed and discussed the promising outcomes data from over 500 RefluxStop procedures performed in Europe. “It is exciting to see the interest and enthusiasm about RefluxStop in the US well ahead of our targeted upcoming US launch,” said Dr. Peter

Invitation to presentation of Q3 2023 financial results

Viaplay Group will publish its Q3 2023 financial results at 07:30 CET on Tuesday 24 October. A conference call will be held at 09:00 CET on Tuesday 24 October with presentations from Jørgen Madsen Lindemann, President and CEO, and Enrique Patrickson, Chief Financial Officer. The call will be hosted by Matthew Hooper, Chief Corporate Affairs Officer, and a question-and-answer session will follow the presentations.   OnlineTo view slides and listen to the conference call online use the following link, where questions can also be posted: https://edge.media-server.com/mmc/p/5yi85awm

Metso launches the first hydrogen LowNOx burner for traveling grate pelletizing plants

Metso Corporation’s press release on October 10, 2023, at 09:00 a.m. EESTMetso is introducing a hydrogen-variant of the Ferroflame[TM ]LowNOx burners as part of its NextGen Pelletizing[TM] plant product range. It is a first-of-its-kind burner to run on hydrogen and to operate on the LowNOx combustion principle. Designed especially for the traveling grate pelletizing plants, these burners are 100% hydrogen powered and are part of Metso’s Planet Positive  offering focused on environmentally efficient technologies.

Invitation to Stora Enso’s Q3 2023 results webcast on 24 October 2023

STORA ENSO OYJ INVESTOR NEWS 10 October 2023 at 9:00 EESTStora Enso will publish its January–September 2023 Interim Report on Tuesday 24 October 2023 at approximately 8:30 am EEST (7:30 CEST).Webcast at 11:00 am EEST (10:00 CEST, 9:00 BST, 4:00 EDT)Analysts, investors, and media are invited to participate in the webcast with a teleconference on the same day. The results will be presented by President and CEO Hans Sohlström and CFO Seppo Parvi. The presentation can be followed live via the link: https://stora-ensos-q3-oct-2023-results.open-exchange.net/. The webcast link will also be

Ground Screws: A Revolutionary Solution to Tackle the Issue of Costly House Building in the UK

The housing crisis in the United Kingdom has become a pressing concern, with the expense of constructing new houses reaching unprecedented heights. As the demand for affordable housing continues to surpass supply, there is a dire need for inventive solutions. Enter ground screws, a pioneering construction method that holds the potential to reshape the landscape of affordable house building in the UK. StopDigging , originating from Sweden, are pioneering the introduction of using ground screws as a credible alternative to traditional ground screw methods,

Tobii launches UX Explore cloud platform, making eye-tracking-based mobile UX research more scalable

The latest product from Tobii, UX Explore , empowers user experience (UX) researchers to harness the power of eye tracking and measure user attention using only a smartphone. The new software-based platform uses deep learning eye tracking algorithms and allows studies to be conducted remotely, accessing users in their natural environment.   Mobile applications are the dominant method to deliver software, boasting over 255 billion downloads in 2022[1] and millions of new apps being developed every year[2].

Skanska delivers fit out and construction work for data centre in London, UK, for GBP 158M, about SEK 2.1 billion

Skanska has signed a contract with Telehouse for a data centre project in Docklands, London, UK. The contract is worth GBP 158M, about SEK 2.1 billion, which will be included in the order bookings for Europe for the fourth quarter of 2023.The work involves the mechanical and electrical fit out of two of the floors, together with the installation of extra plant and infrastructure. It also includes other construction work in support of the development of the facility. Early works have already started, and the project is scheduled to be completed in June 2024.

NCC to build new district court house in Tönsberg, Norway

NCC has been contracted by the Norwegian Directorate of Public Construction and Property to build a new district court house in Tönsberg in south-eastern Norway. The order value is approximately SEK 170 million. The new district court house will cover an area of 4,715 square meters and will contain 14 courtrooms, meeting rooms, waiting rooms, and office space for about 60 people. Together with Dyrvik arkitekter, the Norwegian Directorate of Public Construction and Property and the Norwegian National Courts Administration, NCC has recently completed a seven-week phase to

Lyvia Group secures SEK 1.6 billion in financing through partnership with leading banks

October 10[th], 2023: Lyvia Group, a leading provider of business-critical software and expert services, is proud to announce a new partnership with leading banks Danske Bank and DNB.Lyvia Group’s mission is to drive digital evolution by developing and delivering leading technologies that combine software and expert services for business-critical applications. This new partnership with two major Nordic banks will strengthen the company's growth capabilities and open new opportunities to support Lyvia on its continued European expansion path. "It was natural for us to team up with DNB and

Quickbit starts collaboration with RightBridge Ventures Group - invests in Esport and Gaming

Today, Quickbit announces that it has entered into a partnership with the investment company RightBridge Ventures Group (“RightBridge”), which focuses on Esports and Gaming. The collaboration aims to utilize RightBridge's expertise, market knowledge and reach within the Gaming segment to effectively expand the customer base for both Quickbit Pay and Quickbit App.Quickbit has, as a result of its strategy and market work, identified Esports and Gaming as a segment with high potential for growth. Due to that, Quickbit is now increasing its focus on effectively penetrating the segment by

RightBridge Ventures Group acts as an advisor and strategic partner to Quickbit to boost their growth within Esports and Gaming.

RightBridge Ventures Group ("RightBridge Ventures") has entered into a commercial agreement with Quickbit to offer market and strategic advice on how to enter the Esports and Gaming market as the leading provider of cryptocurrency payment solutions. Additionally, RightBridge Ventures will leverage its portfolio of companies to expedite Quickbit's market launch within this segment.Quickbit, a leader in the cryptocurrency payment industry, has developed a user-friendly payment solution enabling transactions between sellers and consumers using cryptocurrencies. As the popularity of

Sedana Medical receives market approval in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted Sedana Medical AB (publ) marketing authorization for the company’s pharmaceutical product Sedaconda[®] (isoflurane) in the United Kingdom.This market approval will enable Sedana Medical to sell Sedaconda® (isoflurane) in the UK and to promote the clinical and health economic benefits of its therapy for inhaled sedation in intensive care. The medical device Sedaconda ACD has been sold in the UK for several years, and the company submitted the application for marketing authorization for Sedaconda® (isoflurane) in early

Finland launches a 20-qubit quantum computer – development towards more powerful quantum computers continues

Press release 10 October 2023 Today, VTT launched Finland’s second quantum computer – a 20-qubit superconductive device. The quantum computer is a result of intensive joint technology development between VTT and IQM Quantum Computers, demonstrating the companies’ excellence in developing technologies to scale up quantum computers.ESPOO, Finland (October 10th, 2023) VTT Technical Research Centre of Finland  and the European leader in building quantum computers, IQM Quantum Computers , have completed Finland's second quantum

Bravida increases energy efficiency at Huddinge Hospital with an order value of SEK 142 million

Bravida has been awarded a project by Locum to install ventilation, heating, electrical, automation and sprinkler systems in part of Huddinge Hospital. The technical upgrade will enable benefits such as an improved indoor climate for healthcare activities and reduced energy usage to be achieved.Bravida is carrying out the installations in the C2 building at Huddinge Hospital, which contains laboratory and specialised facilities utilised by the entire Region Stockholm; these have high demands, among other things, regarding ventilation and maintained operational reliability.“We are proud to

NCC to construct production facility in Denmark

NCC has been commissioned to construct a production facility in Denmark. The order value is approximately SEK 900 million.The production facility covers 70,000 square meters and NCC’s assignment consists of foundation engineering and the construction of a shell building with a concrete frame. The customer is undisclosed at this time. Foundation engineering work has commenced, and construction of the building will begin in late 2023. Completion of the project is expected at the end of 2025. The value of the foundation engineering assignment totals approximately SEK 50 million and was

Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology

Circio and Neoregen Biotech today announce the start of a research collaboration on novel circular RNA (circRNA) therapeutics based on Circio´s proprietary circVec technology. The parties will test the ability of Neoregen´s NICT (Neoregen Intra-Cellular delivery Technology) delivery system to enhance cellular uptake and nuclear transfer of circVec vectors compared to commercially available delivery technologies. circRNA is an emerging class of novel RNA-therapeutics that offers improved durability and enhanced protein expression compared to mRNA. Due to these potentially significant

Irisity's Operations in Israel Remain Unaffected Amidst Recent Terrorist Attacks.

Irisity AB (publ), a forefront AI video analytics provider, wishes to inform its stakeholders about the current state of its operations in the wake of the devastating terrorist attacks that occurred in Israel this past weekend. With its second largest office situated in Tel Aviv and a workforce of over thirty dedicated employees in the region, the safety and well-being of our team are paramount. The company unequivocally condemns these acts of violence and extends its heartfelt condolences to the victims, their loved ones, and all who have been adversely affected by these tragic events.

Nordea Bank Abp: Repurchase of own shares on 09.10.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares09.10.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 09.10.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |64,394 |10.26 |660,894.94

Join Chiquita in Making a ‘Small Change’ to Inspire a ‘Big Difference’ Through Sticker Series

Chiquita once again joins forces with American Cancer Society for Breast Cancer Awareness MonthFort Lauderdale, FL – October 9, 2023 – For the seventh year in a row, Chiquita is giving its iconic Blue Sticker a makeover in honor of National Breast Cancer Awareness Month. The new Pink Sticker, made to match the Pink Ribbon, an international symbol for breast cancer awareness, will adorn 200 million of Chiquita’s tasty yellow bananas worldwide. This small change, made in partnership with the American Cancer Society (ACS) , aims to help inspire women to make a big

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 09 October 2023 the Company bought 170,592 of its own shares for cancellation at a price of 207.780 pence per share.  The Company's issued ordinary share capital is 561,017,784 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 475,388,236. The above figure (475,388,236) may be used by shareholders as the denominator for the

Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487

HNSA-5487 is a next-generation IgG-cleaving enzyme and the lead candidate in the NiceR development programLund, Sweden, October 9, 2023. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced high-level results from NICE-01, the first-in-human trial for HNSA-5487. Results showed the molecule was safe and well tolerated. Fast and complete depletion of immunoglobulin G (IgG) antibodies was observed at increasing doses in all subjects. Pharmacokinetics (PK) was in line with expectations and pharmacodynamics (PD) (

There are no items matching the current filter
There are no more items matching the current filter
Back to top